Health Canada has approved Medtronic’s MiniMed 670G insulin pump system for use by Type 1 diabetes patients.
The device automatically adjusts basal insulin delivery to stabilize glucose levels and meet the patient’s real-time needs. It was specifically approved for patients seven years of age or older with Type 1 diabetes.
The company said that it expects to launch the insulin pump in Canada this fall. About 300,000 Canadians have Type 1 diabetes.